INmune Bio
INMB
INMB
57 hedge funds and large institutions have $40.3M invested in INmune Bio in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 51 → 57 (+6)
7.9% more ownership
Funds ownership: 15.2% → 23.1% (+7.9%)
Holders
57
Holding in Top 10
1
Calls
$765K
Puts
$492K
Top Buyers
| 1 | +$5.88M | |
| 2 | +$5.65M | |
| 3 | +$4.78M | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$2.24M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.5M |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$1.1M | |
| 3 | -$869K | |
| 4 |
Goldman Sachs
New York
|
-$749K |
| 5 |
Millennium Management
New York
|
-$656K |